Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

59.55
Delayed Data
As of Feb 12
 +2.59 / +4.55%
Today’s Change
51.51
Today|||52-Week Range
140.00
-36.74%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Sanofi
Buy2/01/2016205,030$69.75$14.3M-14.62%
Greene Barry E
President & Chief Operating Officer
Sale5/26/201567,379$125.00$8.4M-53.43%
Starr Kevin Paul
Director
Sale11/12/201535,400$100.01$3.5M-39.81%
Sharp Phillip Allen
Director
Sale12/04/201530,000$109.00$3.3M-45.35%
Maraganore John M
Chief Executive Officer
Sale11/20/201527,137$102.34$2.8M-41.96%
Maraganore John M
Chief Executive Officer
Sale11/20/201523,483$103.13$2.4M-41.96%
Maraganore John M
Chief Executive Officer
Sale12/02/201520,238$105.16$2.1M-42.52%
Maraganore John M
Chief Executive Officer
Sale12/02/201516,984$106.02$1.8M-42.52%
Starr Kevin Paul
Director
Sale11/11/201515,499$108.23$1.7M-42.90%
Starr Kevin Paul
Director
Sale11/11/201512,606$107.39$1.4M-42.90%
Page of 10